Abstract
Obesity is a rising global epidemic associated with metabolic disorders such as diabetes and insulin resistance. While dietary plans and exercise are standard weight loss options, achieving and maintaining weight loss is challenging, often leading to demoralization when results are not immediately visible. Current technology tracks calorie intake but lacks a direct biological link to immediate weight loss progress. This study identifies Angiotensin Converting Enzyme (ACE) as a potential quantitative, science-based biomarker that responds to caloric restriction within a 24-hour interval, offering a biological feedback loop to sustain dieter motivation.
Introduction
The primary hurdle in weight loss is the "laggy" feedback loop. Traditional scales often fail to reflect a single day of caloric restriction due to water retention and metabolic noise, which can discourage individuals. While wearables track activity, there is a critical need for a biological marker that confirms a physiological response to dieting in real-time. This research explores whether ACE levels can serve as a high-frequency metabolic sensor to provide the personalized reinforcement necessary for long-term behavioral change.
Methods
The study monitored 47 participants (mean BMI 27 ± 5) over a 24-hour dietary intervention.
- Dietary Protocol: Participants adhered to a 1,200 Kcal diet, with an optional snack of less than 250 Kcal.
- Data Collection: An in-house digital health platform logged food intake and physical activity. Urine samples were collected to measure ACE concentrations.
- Biochemical Analysis: ACE levels were quantified using a Human ACE DuoSet ELISA (Enzyme-Linked Immunosorbent Assay).
- Statistical Analysis: Pearson correlations and Mann-Whitney U tests were performed using R to evaluate the relationship between ACE fluctuations, BMI, and weight change.
Key Results and Insights
The study demonstrated that ACE levels are dynamic enough to reflect caloric restriction within a 24-hour window, shifting its clinical utility from a static cardiovascular marker to a real-time metabolic indicator.
BMI-Specific Sensitivity
The correlation between ACE levels and weight loss was significantly more robust in individuals with a BMI > 25. A clear linear trend was observed in this group, reinforcing its potential as a reliable metric for overweight and obese populations.
Predictive Power in Female Participants
In female participants, specific ACE metrics were strong predictors of weight loss. The "minimum ACE amount" recorded during the 24-hour window showed a strong negative correlation with weight lost ($R^2 = -0.453, p = 0.034$), meaning a lower "ACE floor" was associated with greater weight reduction. Additionally, the following day's ACE concentration positively correlated with weight difference ($R^2 = 0.482, p = 0.031$).
Discussion and Limitations
These findings propose ACE as the "biological engine" for a new generation of health technology that moves beyond simple calorie counting toward biological response monitoring. However, several limitations remain:
- Scale and Duration: The 24-hour study duration and small sample size (n=47) necessitate longer-term validation to ensure these correlations persist over weeks or months.
- Accessibility: ELISA testing is currently laboratory-bound. For ACE to function as a personalized feedback tool, it must be integrated into portable, point-of-care devices (e.g., urine-based test strips).
- Mechanistic Depth: Further research is required to fully elucidate the physiological pathways linking rapid caloric deficits to ACE fluctuations and to rule out confounding factors like hydration.
Conclusion
ACE represents a promising biomarker for providing immediate, science-based feedback to individuals on a weight loss journey. By closing the feedback loop within 24 hours, ACE-based monitoring could significantly improve adherence and outcomes in obesity management.
Summary updated